Searched for
FDI PHARMA
How India can win in a rewired global economyIndia is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...- India's productivity gap with China widens despite strong GDP growth; manufacturing leap still missing: ReportIndia's labour productivity gap with China has widened significantly since 2000, despite strong economic growth. The country has yet to ach...
- We expect interest rates to be left the way they are: Ficci chief Anant GoenkaFicci president Anant Goenka advocates for steady interest rates, citing supply-side price pressures from the West Asia crisis. He suggests...
- India-Oman CEPA kicks in June 1: What gets cheaper, which sectors gain, and key benefits explainedIndia's Comprehensive Economic Partnership Agreement with Oman comes into effect on June 1, granting New Delhi 100% duty-free access for 98...
- What running a business in India actually looks like: Nightmare of CEOs these days is conversion of commercial disputes into criminal casesA corporate crisis manager describes how business disputes in India are increasingly being turned into criminal cases, exposing executives ...
- Containing war impact on growth, current account: PMO stitching up plan to boost foreign fund flowOfficials at both the finance ministry and Niti Aayog are identifying economic opportunities presented by the Iran conflict, as well as gau...
- Govt has eased FDI norms for foreign cos having small Chinese/Hong Kong stake: An explainerIndia has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...
- India–New Zealand sign 'once-in-a-generation' FTAIndia and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...
- India's 30-year economic model is over; time to pivot from IT to manufacturing: Saurabh MukherjeaSaurabh Mukherjea believes India's long-standing economic model is concluding. He anticipates rising inflation and a weakening rupee impact...
- Pharma sector to grow by 20 per cent on relaxed FDI norms: Ananth Kumar"The pharma industry is growing by 14 per cent every year. With relaxed FDI norms, I think pharma sector will grow by 20 per cent," Kumar s...
- Government weighs relaxing FDI norms in brownfield pharma companiesAccording to a proposal, FDI up to 49% should be allowed through the automatic route and anything beyond through approval of the FIPB, sour...
- Panel for blanket ban on FDI in brown field pharma unitsThe committee demands caution on the issue from the government and reiterates its recommendation to impose a blanket ban in FDI in brown fi...
- FDI in pharma sector jumps 86.5% during April-Oct periodFDI in drugs and pharmaceuticals was at $580 million during April-October 2012, according to the data of the Department of Industrial Polic...
- Government not to reduce FDI cap in existing pharma companiesCurrently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board (FIPB).
- Cabinet defers decision on FDI in pharma, housingThe decision on FDI in pharma and housing has been deferred, Information and Broadcasting Minister Manish Tewari said after the Cabinet mee...
- Commerce Ministry seeks 49% FII, FDI cap in existing drug companiesThe Ministry of Commerce and Industry has proposed tighter overseas investment norms in existing drug companies by limiting all forms of fo...
- FDI in pharma sector doubled during April-AugustFaced with rush of multinationals to acquire Indian pharma firms, the Commerce and Industry Ministry is proposing to tighten the FDI policy...
- Anand Sharma wants Prime Minister to convene meet to review FDI policy in pharmaCommerce Minister Anand Sharma has urged Prime Minister Manmohan Singh to convene a high-level review meeting to deliberate on the matter.
- Is FDI in pharma giving desired results, wonders DIPPThe DIPP said current norms must lay down the foundation of what should be the nature of Indian drug companies in the long term.
- Govt to finalise FDI policy in pharma before FIPB meetThe government is likely to finalise FDI policy with regard to existing drug companies ahead of the FIPB meeting on July 5.
Load More
